Author

J. Mietz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Assay:flow cytometry· 1 Assay:proteomics· 1

Frequent Co-Authors

L. Egli· 2 shared O. Chijioke· 2 shared A. Holtermann· 1 shared B. Arnold· 1 shared C. Munz· 1 shared C. Münz· 1 shared C. Schultheiss· 1 shared C. Stuehler· 1 shared

Activity by Year

2023-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. Egli

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Human effector CD8+ T cells with an exhausted-like phenotype control tumor growth in vivo in a humanized tumor model

J. Mietz, M. Kaulfuss, L. Egli, L. Opitz, C. Munz, O. Chijioke

This study establishes an immunocompetent humanized tumor model and identifies exhausted-like CD8+ T cells with antitumor activity in vivo.

bioRxiv · Oct 11, 2023 · PreprintImmunology

Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

F. Maerkl, C. Schultheiss, M. Ali, S.-S. Chen, L. Egli, J. Mietz, O. Chijoke, L. Paschold, S. Spajic, A. Holtermann, J. Doerr, S. Stock, I. Piseddu, D. Anz, M. Duehren-von Minden, , M. Binder

This study develops CAR T cells targeting a specific mutation in CLL to selectively kill cancer cells while sparing healthy B cells.

bioRxiv · Sep 29, 2023 · PreprintCancer Biology

Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist in vivo

D. Palianina, J. Mietz, C. Stuehler, B. Arnold, G. R. Bantug, C. Münz, O. Chijioke, N. Khanna

This study develops a protocol to expand EBV-specific stem cell memory T cells, showing improved tumor control and persistence in a PTLD model compared to existing ACT methods.

bioRxiv · May 30, 2023 · PreprintImmunology